{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:26:57Z","timestamp":1772166417186,"version":"3.50.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T00:00:00Z","timestamp":1593043200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T00:00:00Z","timestamp":1593043200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009243","name":"Direction G\u00e9n\u00e9rale de l\u2019offre de Soins","doi-asserted-by":"publisher","award":["16-0290"],"award-info":[{"award-number":["16-0290"]}],"id":[{"id":"10.13039\/501100009243","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Acne vulgaris has increased in women over the past 10\u2009years; it currently affects 20\u201330% of women. The physiopathology of adult female acne is distinguished from that of teenagers essentially by two factors: hormonal and inflammatory. On a therapeutic plan, the four types of systemic treatment approved for female acne include cyclines (leading to bacterial resistance); zinc salts (less effective than cyclines); and antiandrogens (risks of phlebitis). The last alternative is represented by isotretinoin, but its use in women of childbearing potential is discouraged because of the teratogen risks. In this context, spironolactone could represent an interesting alternative. It blocks the 5-alpha-reductase receptors at the sebaceous gland and inhibits luteinizing hormone (LH) production at the pituitary level. It has no isotretinoin constraints and does not lead to bacterial resistance. Currently, very few studies have been performed in a limited number of patients: the studies showed that at low doses (lower than 200\u2009mg\/day), spironolactone can be effective against acne. In that context, it is clearly of interest to perform the first double-blind randomized study of spironolactone versus cyclines, which remains the moderate acne reference treatment, and to demonstrate the superiority of spironolactone\u2019s efficacy in order to establish it as an alternative to cyclines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Two hundred female patients will be included. They must have acne vulgaris with at least 10 inflammatory lesions and no more than 3 nodules. After randomization, the patients will be treated by spironolactone or doxycycline for 3 months and after placebo. The study will be blind for the first 6 months and open for the last 6 months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>The treatment frequently used in female acne is systemic antibiotics with many courses, as it is a chronic inflammatory disease. In the context of the recent World Health Organisation (WHO) revelation about the serious, worldwide threat to public health of antibiotic resistance, this trial could give the physician another alternative in the treatment of adult female acne instead of using isotretinoin, which is more complex to manage.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      ClinicalTrials.gov:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03334682\">NCT03334682<\/jats:ext-link>\n                      . Registered on 7 November 2017.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13063-020-04432-w","type":"journal-article","created":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T15:02:27Z","timestamp":1593097347000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["FASCE, the benefit of spironolactone for treating acne in women: study protocol for a randomized double-blind trial"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4183-483X","authenticated-orcid":false,"given":"Alexandra","family":"Poinas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Lemoigne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Le Naour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Michel","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sol\u00e8ne","family":"Schirr-Bonnans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valery-Pierre","family":"Riche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence","family":"Vrignaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurent","family":"Machet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Paul","family":"Claudel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Th\u00e9r\u00e8se","family":"Leccia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewa","family":"Hainaut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Beneton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9cile","family":"Dert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aur\u00e9lie","family":"Boisrobert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurent","family":"Flet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Chiffoleau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phane","family":"Corvec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir","family":"Khammari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brigitte","family":"Dr\u00e9no","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,25]]},"reference":[{"key":"4432_CR1","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/bjd.12149","volume":"168","author":"K Bhate","year":"2013","unstructured":"Bhate K, Williams HC. Epidemiology of acne vulgaris. Br J Dermatol. 2013;168:474\u201385.","journal-title":"Br J Dermatol"},{"key":"4432_CR2","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1046\/j.1468-3083.2001.00357.x","volume":"15","author":"F Poli","year":"2001","unstructured":"Poli F, Dreno B, Verschoore M. An epidemiological study of acne in female adults: results of a survey conducted in France. J Eur Acad Dermatol Venereol. 2001;15:541\u20135.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4432_CR3","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/S0190-9622(99)80056-5","volume":"41","author":"V Goulden","year":"1999","unstructured":"Goulden V, Stables GI, Cunliffe WJ. Prevalence of facial acne in adults. J Am Acad Dermatol. 1999;41:577\u201380. https:\/\/doi.org\/10.1016\/S0190-9622(99)80056-5.","journal-title":"J Am Acad Dermatol"},{"key":"4432_CR4","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jaad.2007.06.045","volume":"58","author":"CN Collier","year":"2008","unstructured":"Collier CN, Harper JC, Cafardi JA, Cantrell WC, Wang W, Foster KW, et al. The prevalence of acne in adults 20 years and older. J Am Acad Dermatol. 2008;58:56\u20139.","journal-title":"J Am Acad Dermatol"},{"key":"4432_CR5","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1468-3083.2011.04214.x","volume":"26","author":"S Preneau","year":"2012","unstructured":"Preneau S, Dreno B. Female acne - a different subtype of teenager acne? J Eur Acad Dermatol Venereol. 2012;26:277\u201382.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4432_CR6","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/jdv.12061","volume":"27","author":"B Dr\u00e9no","year":"2013","unstructured":"Dr\u00e9no B, Layton A, Zouboulis CC, L\u00f3pez-Estebaranz JL, Zalewska-Janowska A, Bagatin E, et al. Adult female acne: a new paradigm. J Eur Acad Dermatol Venereol. 2013;27:1063\u201370.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4432_CR7","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1111\/jdv.12757","volume":"29","author":"B Dr\u00e9no","year":"2015","unstructured":"Dr\u00e9no B, Thiboutot D, Layton AM, Berson D, Perez M, Kang S, et al. Large-scale international study enhances understanding of an emerging acne population: adult females. J Eur Acad Dermatol Venereol. 2015;29:1096\u2013106.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4432_CR8","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1067\/mjd.2000.105557","volume":"43","author":"JC Shaw","year":"2000","unstructured":"Shaw JC. Low-dose adjunctive spironolactone in the treatment of acne in women: a retrospective analysis of 85 consecutively treated patients. J Am Acad Dermatol. 2000;43:498\u2013502.","journal-title":"J Am Acad Dermatol"},{"key":"4432_CR9","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1046\/j.1365-2133.2000.03669.x","volume":"143","author":"D Cibula","year":"2000","unstructured":"Cibula D, Hill M, Vohradnikova O, Kuzel D, Fanta M, Zivny J. The role of androgens in determining acne severity in adult women. Br J Dermatol. 2000;143:399\u2013404.","journal-title":"Br J Dermatol"},{"key":"4432_CR10","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/1523-1747.ep12874121","volume":"94","author":"P Vexiau","year":"1990","unstructured":"Vexiau P, Husson C, Chivot M, Brerault JL, Fiet J, Julien R, et al. Androgen excess in women with acne alone compared with women with acne and\/or hirsutism. J Invest Dermatol. 1990;94:279\u201383.","journal-title":"J Invest Dermatol"},{"key":"4432_CR11","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/00015550410023248","volume":"84","author":"F Borgia","year":"2004","unstructured":"Borgia F, Cannav\u00f2 S, Guarneri F, Cannav\u00f2 SP, Vaccaro M, Guarneri B. Correlation between endocrinological parameters and acne severity in adult women. Acta Derm Venereol. 2004;84:201\u20134.","journal-title":"Acta Derm Venereol"},{"key":"4432_CR12","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/j.1365-4632.2007.03411.x","volume":"46","author":"H Seirafi","year":"2007","unstructured":"Seirafi H, Farnaghi F, Vasheghani-Farahani A, Alirezaie N-S, Esfahanian F, Firooz A, et al. Assessment of androgens in women with adult-onset acne. Int J Dermatol. 2007;46:1188\u201391.","journal-title":"Int J Dermatol"},{"key":"4432_CR13","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/BF00373355","volume":"284","author":"H Aizawa","year":"1993","unstructured":"Aizawa H, Niimura M. Adrenal androgen abnormalities in women with late onset and persistent acne. Arch Dermatol Res. 1993;284:451\u20135.","journal-title":"Arch Dermatol Res"},{"key":"4432_CR14","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1001\/archderm.141.3.333","volume":"141","author":"M Cappel","year":"2005","unstructured":"Cappel M, Mauger D, Thiboutot D. Correlation between serum levels of insulin-like growth factor 1, dehydroepiandrosterone sulfate, and dihydrotestosterone and acne lesion counts in adult women. Arch Dermatol. 2005;141:333\u20138.","journal-title":"Arch Dermatol"},{"issue":"3","key":"4432_CR15","first-page":"12","volume":"76","author":"I Truter","year":"2009","unstructured":"Truter I. Acne vulgaris. SA Pharm J. 2009;76(3):12\u20139.","journal-title":"SA Pharm J"},{"key":"4432_CR16","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1684\/ejd.2014.2309","volume":"24","author":"B Dreno","year":"2014","unstructured":"Dreno B, Thiboutot D, Gollnick H, Bettoli V, Kang S, Leyden JJ, et al. Antibiotic stewardship in dermatology: limiting antibiotic use in acne. Eur J Dermatol. 2014;24:330\u20134.","journal-title":"Eur J Dermatol"},{"key":"4432_CR17","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000051728","volume":"203","author":"B Dreno","year":"2001","unstructured":"Dreno B, Moyse D, Alirezai M, Amblard P, Auffret N, Beylot C, et al. Multicenter randomized comparative double-blind controlled clinical trial of the safety and efficacy of zinc gluconate versus minocycline hydrochloride in the treatment of inflammatory acne vulgaris. Dermatology (Basel). 2001;203:135\u201340.","journal-title":"Dermatology (Basel)"},{"key":"4432_CR18","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1159\/000090658","volume":"212","author":"G Qu\u00e9reux","year":"2006","unstructured":"Qu\u00e9reux G, Volteau C, N\u2019Guyen JM, Dr\u00e9no B. Prospective study of risk factors of relapse after treatment of acne with oral isotretinoin. Dermatology (Basel). 2006;212:168\u201376.","journal-title":"Dermatology (Basel)"},{"key":"4432_CR19","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1056\/NEJMcp033487","volume":"352","author":"WD James","year":"2005","unstructured":"James WD. Clinical practice. Acne N Engl J Med. 2005;352:1463\u201372.","journal-title":"Acne N Engl J Med"},{"key":"4432_CR20","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.sder.2008.06.002","volume":"27","author":"R George","year":"2008","unstructured":"George R, Clarke S, Thiboutot D. Hormonal therapy for acne. Semin Cutan Med Surg. 2008;27:188\u201396.","journal-title":"Semin Cutan Med Surg"},{"key":"4432_CR21","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/1523-1747.ep12472325","volume":"100","author":"H Akamatsu","year":"1993","unstructured":"Akamatsu H, Zouboulis CC, Orfanos CE. Spironolactone directly inhibits proliferation of cultured human facial sebocytes and acts antagonistically to testosterone and 5 alpha-dihydrotestosterone in vitro. J Invest Dermatol. 1993;100:660\u20132.","journal-title":"J Invest Dermatol"},{"key":"4432_CR22","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s40257-016-0245-x","volume":"18","author":"AM Layton","year":"2017","unstructured":"Layton AM, Eady EA, Whitehouse H, Del Rosso JQ, Fedorowicz Z, van Zuuren EJ. Oral spironolactone for acne vulgaris in adult females: a hybrid systematic review. Am J Clin Dermatol. 2017;18:169\u201391.","journal-title":"Am J Clin Dermatol"},{"key":"4432_CR23","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1468-3083.2005.01072.x","volume":"19","author":"A Yemisci","year":"2005","unstructured":"Yemisci A, Gorgulu A, Piskin S. Effects and side-effects of spironolactone therapy in women with acne. J Eur Acad Dermatol Venereol. 2005;19:163\u20136.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4432_CR24","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1365-2133.1985.tb02305.x","volume":"112","author":"BM Burke","year":"1985","unstructured":"Burke BM, Cunliffe WJ. Oral spironolactone therapy for female patients with acne, hirsutism or androgenic alopecia. Br J Dermatol. 1985;112:124\u20135.","journal-title":"Br J Dermatol"},{"key":"4432_CR25","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1365-2133.1986.tb05722.x","volume":"115","author":"MF Muhlemann","year":"1986","unstructured":"Muhlemann MF, Carter GD, Cream JJ, Wise P. Oral spironolactone: an effective treatment for acne vulgaris in women. Br J Dermatol. 1986;115:227\u201332.","journal-title":"Br J Dermatol"},{"key":"4432_CR26","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1001\/archderm.134.9.1162-a","volume":"134","author":"HG Lubbos","year":"1998","unstructured":"Lubbos HG, Hasinski S, Rose LI, Pollock J. Adverse effects of spironolactone therapy in women with acne. Arch Dermatol. 1998;134:1162\u20133.","journal-title":"Arch Dermatol"},{"key":"4432_CR27","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jaad.2007.09.024","volume":"58","author":"A Krunic","year":"2008","unstructured":"Krunic A, Ciurea A, Scheman A. Efficacy and tolerance of acne treatment using both spironolactone and a combined contraceptive containing drospirenone. J Am Acad Dermatol. 2008;58:60\u20132.","journal-title":"J Am Acad Dermatol"},{"key":"4432_CR28","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2133.1984.tb04045.x","volume":"111","author":"A Goodfellow","year":"1984","unstructured":"Goodfellow A, Alaghband-Zadeh J, Carter G, Cream JJ, Holland S, Scully J, et al. Oral spironolactone improves acne vulgaris and reduces sebum excretion. Br J Dermatol. 1984;111:209\u201314.","journal-title":"Br J Dermatol"},{"key":"4432_CR29","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1111\/j.1468-3083.2010.03926.x","volume":"25","author":"M Saint-Jean","year":"2011","unstructured":"Saint-Jean M, Ballanger F, Nguyen JM, Khammari A, Dr\u00e9no B. Importance of spironolactone in the treatment of acne in adult women. J Eur Acad Dermatol Venereol. 2011;25:1480\u20131.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4432_CR30","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1684\/ejd.2017.3062","volume":"27","author":"A Isvy-Joubert","year":"2017","unstructured":"Isvy-Joubert A, Nguyen J-M, Gaultier A, Saint-Jean M, Le Moigne M, Boisrobert E, et al. Adult female acne treated with spironolactone: a retrospective data review of 70 cases. Eur J Dermatol. 2017;27:393\u20138.","journal-title":"Eur J Dermatol"},{"key":"4432_CR31","volume-title":"Antimicrobial resistance - global report on surveillance","author":"World Health Organization","year":"2014","unstructured":"World Health Organization. Antimicrobial resistance - global report on surveillance. 2014. https:\/\/www.who.int\/antimicrobial-resistance\/publications\/AMR_report_Web_slide_set.pdf?ua=1. Accessed 20 Dec 2019."},{"key":"4432_CR32","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1067\/mjd.2002.120912","volume":"47","author":"HP Lehmann","year":"2002","unstructured":"Lehmann HP, Robinson KA, Andrews JS, Holloway V, Goodman SN. Acne therapy: a methodologic review. J Am Acad Dermatol. 2002;47:231\u201340.","journal-title":"J Am Acad Dermatol"},{"key":"4432_CR33","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1046\/j.1365-4362.1997.00099.x","volume":"36","author":"A Doshi","year":"1997","unstructured":"Doshi A, Zaheer A, Stiller MJ. A comparison of current acne grading systems and proposal of a novel system. Int J Dermatol. 1997;36:416\u20138.","journal-title":"Int J Dermatol"},{"key":"4432_CR34","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1468-3083.2010.03685.x","volume":"25","author":"B Dr\u00e9no","year":"2011","unstructured":"Dr\u00e9no B, Poli F, Pawin H, Beylot C, Faure M, Chivot M, et al. Development and evaluation of a Global Acne Severity Scale (GEA Scale) suitable for France and Europe. J Eur Acad Dermatol Venereol. 2011;25:43\u20138.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4432_CR35","first-page":"136","volume":"126","author":"B Dreno","year":"1999","unstructured":"Dreno B, Bodokh I, Chivot M, Daniel F, Humbert P, Poli F, et al. ECLA grading: a system of acne classification for every day dermatological practice. Ann Dermatol Venereol. 1999;126:136\u201341.","journal-title":"Ann Dermatol Venereol"},{"key":"4432_CR36","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1111\/jdv.13518","volume":"30","author":"N Auffret","year":"2016","unstructured":"Auffret N, Claudel J-P, Leccia M-T, Poli F, Farhi D, Dr\u00e9no B. AFAST - Adult Female Acne Scoring Tool: an easy-to-use tool for scoring acne in adult females. J Eur Acad Dermatol Venereol. 2016;30:824\u20138.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4432_CR37","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jaad.2007.06.006","volume":"57","author":"DM Thiboutot","year":"2007","unstructured":"Thiboutot DM, Weiss J, Bucko A, Eichenfield L, Jones T, Clark S, et al. Adapalene-benzoyl peroxide, a fixed-dose combination for the treatment of acne vulgaris: results of a multicenter, randomized double-blind, controlled study. J Am Acad Dermatol. 2007;57:791\u20139.","journal-title":"J Am Acad Dermatol"},{"key":"4432_CR38","first-page":"16","volume":"2","author":"TL Ebede","year":"2009","unstructured":"Ebede TL, Arch EL, Berson D. Hormonal treatment of acne in women. J Clin Aesthet Dermatol. 2009;2:16\u201322.","journal-title":"J Clin Aesthet Dermatol"},{"key":"4432_CR39","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1529-8019.2012.01497.x","volume":"25","author":"RM Mays","year":"2012","unstructured":"Mays RM, Gordon RA, Wilson JM, Silapunt S. New antibiotic therapies for acne and rosacea. Dermatol Ther. 2012;25:23\u201337.","journal-title":"Dermatol Ther"},{"key":"4432_CR40","doi-asserted-by":"crossref","unstructured":"Farrah G, Tan E. The use of oral antibiotics in treating acne vulgaris: a new approach. Dermatol Ther. 2016;29(5):377\u201384.","DOI":"10.1111\/dth.12370"},{"key":"4432_CR41","unstructured":"AFSSAPS. Traitement de l\u2019Acn\u00e9 par voie locale et g\u00e9n\u00e9rale. https:\/\/www.ansm.sante.fr\/content\/download\/3918\/38790\/version\/6\/file\/Rbp_Acne-Traitement-voie-locale-generale_2007.pdf. Accessed 20 Dec 2019."},{"issue":"8","key":"4432_CR42","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1111\/jdv.13776","volume":"30","author":"A Nast","year":"2016","unstructured":"Nast A, Dreno B, Bettoli V, Bukvic Mokos K, Degitz K, Dressier C, et al. European evidence-based (S3) guideline for the treatment of Acne -Update 2016- short version. J Eur Acad Dermatol Venereol. 2016;30(8):1261\u20138. https:\/\/doi.org\/10.1111\/jdv.13776.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4432_CR43","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.jaad.2015.12.037","volume":"74","author":"AL Zaenglein","year":"2016","unstructured":"Zaenglein AL, Pathy AL, Schlosser BJ, Alikhan A, Baldwin HE, Berson DS, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016;74:945\u2013973.e33.","journal-title":"J Am Acad Dermatol"},{"key":"4432_CR44","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000067823","volume":"206","author":"D Thiboutot","year":"2003","unstructured":"Thiboutot D, Chen W. Update and future of hormonal therapy in acne. Dermatology (Basel). 2003;206:57\u201367.","journal-title":"Dermatology (Basel)"},{"key":"4432_CR45","first-page":"345","volume":"53","author":"PJ Karanicolas","year":"2010","unstructured":"Karanicolas PJ, Farrokhyar F, Bhandari M. Practical tips for surgical research: blinding: who, what, when, why, how? Can J Surg. 2010;53:345\u20138.","journal-title":"Can J Surg"},{"key":"4432_CR46","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10198-011-0351-x","volume":"14","author":"J Chevalier","year":"2013","unstructured":"Chevalier J, de Pouvourville G. Valuing EQ-5D using time trade-off in France. Eur J Health Econ. 2013;14:57\u201366.","journal-title":"Eur J Health Econ"},{"key":"4432_CR47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2230.1992.tb02521.x","volume":"17","author":"RJ Motley","year":"1992","unstructured":"Motley RJ, Finlay AY. Practical use of a disability index in the routine management of acne. Clin Exp Dermatol. 1992;17:1\u20133.","journal-title":"Clin Exp Dermatol"},{"key":"4432_CR48","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/BF00435978","volume":"5","author":"MS Salek","year":"1996","unstructured":"Salek MS, Khan GK, Finlay AY. Questionnaire techniques in assessing acne handicap: reliability and validity study. Qual Life Res. 1996;5:131\u20138.","journal-title":"Qual Life Res"},{"key":"4432_CR49","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1440-0960.1996.tb00992.x","volume":"37","author":"AM Oakley","year":"1996","unstructured":"Oakley AM. The Acne Disability Index: usefulness confirmed. Australas J Dermatol. 1996;37:37\u20139.","journal-title":"Australas J Dermatol"},{"key":"4432_CR50","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1365-2230.1989.tb00930.x","volume":"14","author":"RJ Motley","year":"1989","unstructured":"Motley RJ, Finlay AY. How much disability is caused by acne? Clin Exp Dermatol. 1989;14:194\u20138.","journal-title":"Clin Exp Dermatol"},{"key":"4432_CR51","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1159\/000076481","volume":"208","author":"B Dreno","year":"2004","unstructured":"Dreno B, Finlay AY, Nocera T, Verri\u00e8re F, Ta\u00efeb C, Myon E. The Cardiff Acne Disability Index: cultural and linguistic validation in French. Dermatology (Basel). 2004;208:104\u20138.","journal-title":"Dermatology (Basel)"},{"key":"4432_CR52","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1001\/jamadermatol.2015.34","volume":"151","author":"M Plovanich","year":"2015","unstructured":"Plovanich M, Weng QY, Mostaghimi A. Low usefulness of potassium monitoring among healthy young women taking spironolactone for acne. JAMA Dermatol. 2015;151:941\u20134.","journal-title":"JAMA Dermatol"},{"key":"4432_CR53","first-page":"264","volume":"89","author":"International Committee of Medical Journal Editors (ICMJE)","year":"2004","unstructured":"International Committee of Medical Journal Editors (ICMJE). Uniform requirements for manuscripts submitted to biomedical journals: writing and editing for biomedical publication. Haematologica. 2004;89:264.","journal-title":"Haematologica"},{"key":"4432_CR54","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.det.2011.09.001","volume":"30","author":"S Knutsen-Larson","year":"2012","unstructured":"Knutsen-Larson S, Dawson AL, Dunnick CA, Dellavalle RP. Acne vulgaris: pathogenesis, treatment, and needs assessment. Dermatol Clin. 2012;30:99\u2013106 viii\u2013ix.","journal-title":"Dermatol Clin"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-020-04432-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-020-04432-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-020-04432-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T19:23:13Z","timestamp":1624562593000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-020-04432-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,25]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["4432"],"URL":"https:\/\/doi.org\/10.1186\/s13063-020-04432-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-20547\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-20547\/v1","asserted-by":"object"}]},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,25]]},"assertion":[{"value":"28 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All patients participating in the study are given oral and written information about this trial and sign the informed consent form.An independent ethical review board, the Comit\u00e9 de Protection des Personnes Sud-Ouest et Outre-mer III, issued a favourable opinion for this clinical trial and gave its approval on 3 October 2017.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests. This study is considered to be externally funded as Prof. Dreno has been awarded government funding (via a funding body).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"571"}}